Literature DB >> 32321720

Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).

Alessandro Giollo1, Giovanni Adami2, Davide Gatti2, Luca Idolazzi2, Maurizio Rossini2.   

Abstract

Entities:  

Keywords:  anti-inflammatory agents, non-steroidal; arthritis, psoriatic; arthritis, rheumatoid; biological therapy; spondylitis, ankylosing

Year:  2020        PMID： 32321720     DOI： 10.1136/annrheumdis-2020-217598

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

Review 1.  Decrypting the cellular and molecular intricacies associated with COVID-19-induced chronic pain.

Authors:  Mousmi Rani; Ankit Uniyal; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2022-07-18       Impact factor: 3.655

Review 2.  Non-steroidal anti-inflammatory drugs in the era of the Covid-19 pandemic in the context of the human and the environment.

Authors:  Danuta Wojcieszyńska; Henryk Guzik; Urszula Guzik
Journal:  Sci Total Environ       Date:  2022-04-19       Impact factor: 10.753

3.  Influence of the containment on the epidemiology of maxillo-facial emergencies during the COVID-19 pandemic. Why no more cellulites of odontogenic origin?

Authors:  J D Kün-Darbois; A Kahn; P Corre
Journal:  J Stomatol Oral Maxillofac Surg       Date:  2020-05-13       Impact factor: 1.569

Review 4.  Implications of COVID-19 in pediatric rheumatology.

Authors:  Ezgi Deniz Batu; Seza Özen
Journal:  Rheumatol Int       Date:  2020-06-04       Impact factor: 2.631

5.  Frequency and phenotype of headache in covid-19: a study of 2194 patients.

Authors:  David García-Azorín; Álvaro Sierra; Javier Trigo; Ana Alberdi; María Blanco; Ismael Calcerrada; Ana Cornejo; Miguel Cubero; Ana Gil; Cristina García-Iglesias; Ana Guiomar Lozano; Cristina Martínez Badillo; Carol Montilla; Marta Mora; Gabriela Núñez; Marina Paniagua; Carolina Pérez; María Rojas; Marta Ruiz; Leticia Sierra; María Luisa Hurtado; Ángel Luis Guerrero Peral
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

Review 6.  Psoriasis and COVID-19: A narrative review with treatment considerations.

Authors:  Ömer Faruk Elmas; Abdullah Demirbaş; Ömer Kutlu; Fatih Bağcıer; Mahmut Sami Metin; Kemal Özyurt; Necmettin Akdeniz; Mustafa Atasoy; Ümit Türsen; Torello Lotti
Journal:  Dermatol Ther       Date:  2020-07-09       Impact factor: 3.858

Review 7.  The rise and evolution of COVID-19.

Authors:  Mohsen Baghchechi; Navin Jaipaul; Sharon E Jacob
Journal:  Int J Womens Dermatol       Date:  2020-06-26

Review 8.  Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic.

Authors:  Mi Ryoung Seo; Ji-Won Kim; Eun-Jung Park; Seung Min Jung; Yoon-Kyoung Sung; Hyungjin Kim; Gunwoo Kim; Hyun-Sook Kim; Myeung-Su Lee; Jisoo Lee; Ji An Hur; Bum Sik Chin; Joong Sik Eom; Han Joo Baek
Journal:  Korean J Intern Med       Date:  2020-09-15       Impact factor: 2.884

9.  Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients.

Authors:  Javier Trigo López; David García-Azorín; Álvaro Planchuelo-Gómez; Cristina García-Iglesias; Carlos Dueñas-Gutiérrez; Ángel L Guerrero
Journal:  Cephalalgia       Date:  2020-11       Impact factor: 6.292

10.  Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence.

Authors:  Mahmoud Yousefifard; Alireza Zali; Afshin Zarghi; Arian Madani Neishaboori; Mostafa Hosseini; Saeed Safari
Journal:  Int J Clin Pract       Date:  2020-06-14       Impact factor: 3.149
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.